Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Washington D.C. DC, Bethesda MD, Hyattsville MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Washington D.C. DC, Annapolis MD, Charlottesville VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Washington D.C. DC, Arlington VA, Bethesda MD,
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
for
Fabry Disease, Pregnancy, Pregnancy Complications
Location: Washington D.C. DC
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: Female
Age: 0+
Code: NCT06941025
Recruiting
Stress, Sleep and Cardiovascular Risk
for
Posttraumatic Stress Disorder, Insomnia
Location: Washington DC
Sponsor: Howard University
Sex: All
Age: 18 - 35
Code: NCT03487991
Recruiting
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
for
Violence Risk, Early Psychosis
Location: Washington D.C. DC
Sponsor: Howard University
Sex: All
Age: 16 - 30
Code: NCT07417904
Recruiting
Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates
for
Osteoporosis
Location: Washington DC
Sponsor: National Bone Health Alliance
Sex: All
Age: 50+
Code: NCT02575157
Recruiting
El Camino HIV Prevention and Care Study
for
HIV Infections
Location: Washington D.C. DC
Sponsor: American University
Sex: Male
Age: 18+
Code: NCT07834853
Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Washington D.C. DC, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1 - 70+
Code: NCT05868629
Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Washington D.C. DC, Baltimore MD, Hershey PA,